Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Nuwellis Inc (NUWE) vs T Rowe Price Group Inc (TROW) Price & Performance

Nuwellis IncTrade
T Rowe Price Group IncTrade

Price performance (Past 24H)

Key statistics

Nuwellis Inc vs T Rowe Price Group Inc — how do they compare? Nuwellis Inc trades at $2.95 (market cap $1.09M), while T Rowe Price Group Inc trades at $115.59 (market cap $25.14B). The key difference: T Rowe Price Group Inc is far larger — about 23064.2× Nuwellis Inc's market cap, and T Rowe Price Group Inc pays a 4.43% dividend while Nuwellis Inc pays none. Which is the better fit depends on your goals.

NUWETROW
Market Cap
$1.09M$25.14B
Sector
TechnologyFinancials
52-Week High
$527.46$120.16
52-Week Low
$2.80$86.19
Enterprise Value
-$722.58K$21.85B
Dividend Yield
4.43%

Returns comparison

Trailing returns across standard periods

About Nuwellis Inc

Nuwellis, Inc. is a medical device company focused on developing and commercializing fluid management solutions. The company's primary product is an ultrafiltration system used in hospitals to remove excess fluid from patients with fluid overload, often associated with conditions such as heart and kidney failure. Nuwellis aims to improve patient outcomes and reduce healthcare costs through its specialized, innovative therapies.

Read more on NUWE

About T Rowe Price Group Inc

T. Rowe Price provides asset-management services for individual and institutional investors. It offers a broad range of no-load U.S. and international stock, hybrid, bond, and money market funds. At the end of August 2022, the firm had $1.339 trillion in managed assets, composed of equity (54%), balanced (30%), fixed-income (13%), and alternatives (3%) offerings. Approximately two thirds of the company's managed assets are held in retirement-based accounts, which provides T. Rowe Price with a somewhat stickier client base than most of its peers. The firm also manages private accounts, provides retirement planning advice, and offers discount brokerage and trust services. The company is primarily a U.S.-based asset manager, deriving just under 10% of its AUM from overseas.

Read more on TROW